Granules India Ltd - 532482 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- CHAITANYA TUMMALADesignation :- Company Secretary and Compliance Officer Granules India Ltd - 532482 - Closure of Trading Window
Intimation of Trading Window Closure Granules India Ltd - 532482 - Completion Of US FDA Audit At GPI Facility
Completion of US FDA audit at GPI facility GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting Granules India Ltd - 532482 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Granules India to invest Rs 1,000 crore over 3 years till FY24 to expand operations
The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Granules India Limited -Q4 and FY 2021 Earnings Conference Call Transcript -RevisedGranules India to donate 16 crore paracetamol tablets to Telangana
Granules India Ltd has pledged to provide 16 crore paracetamol-500 mg tablets free of cost to Telangana Government to fight the covid-19 pandemic.Acc GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting